skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

12 Total results for product and free and sample content found

Scrip

Buyers and Sellers: How Corporate Transactions are Shaping the Big Pharma Landscape

Buyers and Sellers: How Corporate Transactions are Shaping the Big Pharma Landscape

Scrip has been scrutinizing significant M&A deals in the pharma industry in light of companies’ 2019 financial results. We bring you insights into the impact of major acquisitions and divestments by Big Pharma, and consider what it means for the future. 

Topic M A

Scrip

Amid New M&A Rumors, Amarin CEO Focused On Vascepa Approval

Article

John Thero insists company is focused on approval and launch, as interest in European rights grow.

Topic Cardiovascular M A

Biomedtracker

A Historic Decade of Deal Making

A Historic Decade of Deal Making

In preparation for the webinar, download your free infographic, a snapshot view of M&A’s biggest deals and major players and what their activities indicate for the year ahead.

Topic M A

Biomedtracker

A Decade of Biopharma Mergers and Acquisitions and Outlook for 2020 Whitepaper

A Decade of Biopharma Mergers and Acquisitions and Outlook for 2020 Whitepaper

Using M&A activity as a barometer for the overall health of the biopharma industry, we explore biopharma’s biggest deals of the past decade and examine what they may presage for the year to come. Dive into key insights on trends, M&A drivers, companies to watch, and more. 

Topic M A

Scrip

Quick Listen: Scrip's Five Must-Know Things

Scrip August Podcast

Take a brief audio tour around the main biopharma industry events of the past week, as brought to you by Scrip's global team, in this podcast version of Five Must-Know Things.

Topic Coronavirus M A

Pink Sheet

Divided FTC Okays Mylan-Upjohn Merger But Election Outcome Could Impede Future Deals

mylan pfizer upjohn merger

Commissioners vote 3-2 that Mylan and Pfizer’s Upjohn can combine after divesting seven products; dissenting votes focus on price fixing allegations as commissioners Chopra and Slaughter criticize majority for not addressing government’s case against Pfizer and Mylan. Former FTC attorneys note that if Biden wins the presidential election, he could nominate one of the dissenters to FTC chair and give more traction to their views.

Topic US Election 2020 M A Legal Issues

Scrip

Quick Listen: Scrip's Five Must-Know Things

Scrip August Podcast

Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharmaceutical sector. 

Topic Coronavirus M A

In Vivo

In Vivo Deal Making Article Pack

In Vivo Deal Making Article Pack

Gain a view into the market gaps, opportunities, and trends in biopharma with a look at deal-making from In Vivo. Examine how deal-making has impacted the industry and shifted market dynamics and learn how you can use knowledge of these trends to inform your own strategies.

Scrip

Big pharma results through acquisition and divestment?

Big pharma results through acquisition and divestment?

Go behind the headlines from Big Pharma’s year-end conferences for insights into the most significant recent M&A and divestment activities. Scrip takes you inside the strategies of pharma’s leading companies as they enter a new decade.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free   : +1 888 670 8900  
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (20) 805 20700

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: